Targeted Transcriptional Repression by Induced Proximity
Open Access
- 11 June 2026
- journal article
- Published by American Chemical Society (ACS) in ACS Central Science
- Vol. 12 (7) , 1008-1020
Abstract
No abstract availableFunding Information
- Novartis Institutes for BioMedical Research
- Deutsche Forschungsgemeinschaft
- Barbara and Gerson Bakar Foundation
- National Institutes of Health (R01CA240981)
- National Institutes of Health (R35CA263814)
- National Institutes of Health (S10OD024998)
- Mark Foundation For Cancer Research
- National Science Foundation (2127788)
- UC Berkeley Molecular Therapeutics Initiative
This publication has 31 references indexed in Scilit:
- Comparative Analysis of Drug-like EP300/CREBBP Acetyltransferase InhibitorsACS Chemical Biology, 2023
- Genome-wide programmable transcriptional memory by CRISPR-based epigenome editingCell, 2021
- Reimagining Druggability Using Chemoproteomic PlatformsAccounts of Chemical Research, 2021
- BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated DegradationCancer Cell, 2018
- Nrf2-Keap1 signaling in oxidative and reductive stressBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2018
- Drugging the 'undruggable' cancer targetsNature Reviews Cancer, 2017
- ATAC‐seq: A Method for Assaying Chromatin Accessibility Genome‐WideCurrent Protocols in Molecular Biology, 2015
- WNT signalling pathways as therapeutic targets in cancerNature Reviews Cancer, 2012
- Cancer biology and NuRD: a multifaceted chromatin remodelling complexNature Reviews Cancer, 2011
- Facile Synthesis of CIDs: Biotinylated Estrone Oximes Efficiently Heterodimerize Estrogen Receptor and Streptavidin Proteins in Yeast Three Hybrid SystemsOrganic Letters, 2004